阿片类药物使用障碍与脑动脉瘤破裂的关系

IF 3.6 2区 医学 Q1 PSYCHIATRY
Fares Qeadan , Emma M. Federico , Benjamin Tingey , Atif Zafar , Andrew P. Carlson
{"title":"阿片类药物使用障碍与脑动脉瘤破裂的关系","authors":"Fares Qeadan ,&nbsp;Emma M. Federico ,&nbsp;Benjamin Tingey ,&nbsp;Atif Zafar ,&nbsp;Andrew P. Carlson","doi":"10.1016/j.drugalcdep.2025.112896","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>The association between opioid use disorder (OUD) and cerebral aneurysm rupture has been suggested in recent studies. However, these studies are limited to small sample sizes and lack data on medications for opioid use disorder (MOUD). We investigate the association between OUD and cerebral aneurysm rupture in a large database.</div></div><div><h3>Methods</h3><div>A retrospective cohort study was conducted using de-identified electronic health record (EHR) data from Oracle EHR Real-World Data™ (OERWD). Cox proportional hazard regressions were conducted to assess the association between OUD and aneurysm rupture, and the association of MOUD with aneurysm rupture, over different years of follow-up.</div></div><div><h3>Results</h3><div>Patients with OUD (n = 584,125), compared to non-exposures (n = 1752,375) had 54 % higher risk (adjusted hazard ratio (aHR) [95 % confidence interval (CI)]: 1.54 [1.34, 1.76]) of cerebral aneurysm rupture within one year of follow-up and 28 % higher risk (aHR [95 % CI]: 1.28 [1.14, 1.44]) within five years of follow-up. Additionally, patients with OUD and MOUD treatment (n = 83,164), compared to those with OUD but without MOUD (n = 410,466), had 25 % lower risk (aHR [95 % CI]: 0.75 [0.55, 1.01]) of cerebral aneurysm rupture in one year of follow-up and 30 % lower risk (aHR [95 % CI]: 0.70 [0.51, 0.98]) in five years of follow-up.</div></div><div><h3>Conclusions</h3><div>This research identified OUD as a significant risk factor, and MOUD as a protective factor both significant and on the boundary of significance in certain years of follow-up for cerebral aneurysm rupture. These results provide important insight that could encourage future targeted strategies for early intervention and prevention in such patients.</div></div>","PeriodicalId":11322,"journal":{"name":"Drug and alcohol dependence","volume":"276 ","pages":"Article 112896"},"PeriodicalIF":3.6000,"publicationDate":"2025-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The association of opioid use disorder with cerebral aneurysm rupture\",\"authors\":\"Fares Qeadan ,&nbsp;Emma M. Federico ,&nbsp;Benjamin Tingey ,&nbsp;Atif Zafar ,&nbsp;Andrew P. Carlson\",\"doi\":\"10.1016/j.drugalcdep.2025.112896\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>The association between opioid use disorder (OUD) and cerebral aneurysm rupture has been suggested in recent studies. However, these studies are limited to small sample sizes and lack data on medications for opioid use disorder (MOUD). We investigate the association between OUD and cerebral aneurysm rupture in a large database.</div></div><div><h3>Methods</h3><div>A retrospective cohort study was conducted using de-identified electronic health record (EHR) data from Oracle EHR Real-World Data™ (OERWD). Cox proportional hazard regressions were conducted to assess the association between OUD and aneurysm rupture, and the association of MOUD with aneurysm rupture, over different years of follow-up.</div></div><div><h3>Results</h3><div>Patients with OUD (n = 584,125), compared to non-exposures (n = 1752,375) had 54 % higher risk (adjusted hazard ratio (aHR) [95 % confidence interval (CI)]: 1.54 [1.34, 1.76]) of cerebral aneurysm rupture within one year of follow-up and 28 % higher risk (aHR [95 % CI]: 1.28 [1.14, 1.44]) within five years of follow-up. Additionally, patients with OUD and MOUD treatment (n = 83,164), compared to those with OUD but without MOUD (n = 410,466), had 25 % lower risk (aHR [95 % CI]: 0.75 [0.55, 1.01]) of cerebral aneurysm rupture in one year of follow-up and 30 % lower risk (aHR [95 % CI]: 0.70 [0.51, 0.98]) in five years of follow-up.</div></div><div><h3>Conclusions</h3><div>This research identified OUD as a significant risk factor, and MOUD as a protective factor both significant and on the boundary of significance in certain years of follow-up for cerebral aneurysm rupture. These results provide important insight that could encourage future targeted strategies for early intervention and prevention in such patients.</div></div>\",\"PeriodicalId\":11322,\"journal\":{\"name\":\"Drug and alcohol dependence\",\"volume\":\"276 \",\"pages\":\"Article 112896\"},\"PeriodicalIF\":3.6000,\"publicationDate\":\"2025-09-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Drug and alcohol dependence\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0376871625003497\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PSYCHIATRY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug and alcohol dependence","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0376871625003497","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0

摘要

背景最近的研究表明阿片类药物使用障碍(OUD)与脑动脉瘤破裂之间存在关联。然而,这些研究仅限于小样本量,缺乏阿片类药物使用障碍(mod)药物的数据。我们在一个大型数据库中研究OUD与脑动脉瘤破裂之间的关系。方法采用Oracle EHR Real-World data™(OERWD)的去识别电子健康记录(EHR)数据进行回顾性队列研究。在不同的随访年限中,采用Cox比例风险回归来评估OUD与动脉瘤破裂之间的关系,以及OUD与动脉瘤破裂的关系。结果OUD患者(n = 584,125)与未暴露患者(n = 1752,375)相比,随访1年内发生脑动脉瘤破裂的风险(调整风险比(aHR)[95%可信区间(CI)]: 1.54[1.34, 1.76])高出54%,随访5年内发生脑动脉瘤破裂的风险(aHR [95% CI]: 1.28[1.14, 1.44])高出28%。此外,与接受OUD和mod治疗的患者(n = 83,164)相比,OUD但未接受mod治疗的患者(n = 410,466),随访1年脑动脉瘤破裂风险降低25% (aHR [95% CI]: 0.75[0.55, 1.01]),随访5年脑动脉瘤破裂风险降低30% (aHR [95% CI]: 0.70[0.51, 0.98])。结论本研究确定OUD是脑动脉瘤破裂的重要危险因素,而mud是脑动脉瘤破裂的重要保护因素,且在一定随访年限内具有显著性或接近显著性。这些结果提供了重要的见解,可以鼓励未来有针对性的策略,早期干预和预防这些患者。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
The association of opioid use disorder with cerebral aneurysm rupture

Background

The association between opioid use disorder (OUD) and cerebral aneurysm rupture has been suggested in recent studies. However, these studies are limited to small sample sizes and lack data on medications for opioid use disorder (MOUD). We investigate the association between OUD and cerebral aneurysm rupture in a large database.

Methods

A retrospective cohort study was conducted using de-identified electronic health record (EHR) data from Oracle EHR Real-World Data™ (OERWD). Cox proportional hazard regressions were conducted to assess the association between OUD and aneurysm rupture, and the association of MOUD with aneurysm rupture, over different years of follow-up.

Results

Patients with OUD (n = 584,125), compared to non-exposures (n = 1752,375) had 54 % higher risk (adjusted hazard ratio (aHR) [95 % confidence interval (CI)]: 1.54 [1.34, 1.76]) of cerebral aneurysm rupture within one year of follow-up and 28 % higher risk (aHR [95 % CI]: 1.28 [1.14, 1.44]) within five years of follow-up. Additionally, patients with OUD and MOUD treatment (n = 83,164), compared to those with OUD but without MOUD (n = 410,466), had 25 % lower risk (aHR [95 % CI]: 0.75 [0.55, 1.01]) of cerebral aneurysm rupture in one year of follow-up and 30 % lower risk (aHR [95 % CI]: 0.70 [0.51, 0.98]) in five years of follow-up.

Conclusions

This research identified OUD as a significant risk factor, and MOUD as a protective factor both significant and on the boundary of significance in certain years of follow-up for cerebral aneurysm rupture. These results provide important insight that could encourage future targeted strategies for early intervention and prevention in such patients.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Drug and alcohol dependence
Drug and alcohol dependence 医学-精神病学
CiteScore
7.40
自引率
7.10%
发文量
409
审稿时长
41 days
期刊介绍: Drug and Alcohol Dependence is an international journal devoted to publishing original research, scholarly reviews, commentaries, and policy analyses in the area of drug, alcohol and tobacco use and dependence. Articles range from studies of the chemistry of substances of abuse, their actions at molecular and cellular sites, in vitro and in vivo investigations of their biochemical, pharmacological and behavioural actions, laboratory-based and clinical research in humans, substance abuse treatment and prevention research, and studies employing methods from epidemiology, sociology, and economics.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信